{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:26:23Z","timestamp":1791937583619,"version":"4.3.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/nrneph.2009.140","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T13:34:07Z","timestamp":1253799247000},"page":"582-589","source":"Crossref","is-referenced-by-count":38,"title":["Renal transplantation in patients with HIV"],"prefix":"10.1038","volume":"5","author":[{"given":"Lynda A.","family":"Frassetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Tan-Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrneph2009140_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.7326\/0003-4819-101-4-429","volume":"101","author":"V Pardo","year":"1984","unstructured":"Pardo, V.  et al. Glomerular lesions in the acquired immunodeficiency syndrome. Ann. Intern. Med. 101, 429\u2013434 (1984).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneph2009140_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM198403153101101","volume":"310","author":"TK Rao","year":"1984","unstructured":"Rao, T. K.  et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 310, 669\u2013673 (1984).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2009140_CR3","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1097\/01.ASN.0000040750.40907.99","volume":"13","author":"MJ Ross","year":"2002","unstructured":"Ross, M. J. & Klotman, P. E. Recent progress in HIV-associated nephropathy. J. Am. Soc. Nephrol. 13, 2997\u20133004 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009140_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/00126334-200204010-00009","volume":"29","author":"RM Selik","year":"2002","unstructured":"Selik, R. M., Byers, R. H. Jr, & Dworkin, M. S. Trends in diseases reported on U. S. death certificates that mentioned HIV infection 1987\u20131999. J. Acquir. Immune Defic. Syndr. 29, 378\u2013387 (2002).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFnrneph2009140_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1089\/aid.2008.0158","volume":"24","author":"JC Trull\u00e0s","year":"2008","unstructured":"Trull\u00e0s, J. C.  et al. Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48\/05 study. AIDS Res. Hum. Retroviruses 24, 1229\u20131235 (2008).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnrneph2009140_CR6","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1086\/523729","volume":"45","author":"AI Choi","year":"2007","unstructured":"Choi, A. I.  et al. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin. Infect. Dis. 45, 1633\u20131639 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrneph2009140_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2165\/00003495-200868070-00006","volume":"68","author":"DM Fine","year":"2008","unstructured":"Fine, D. M., Perazella, M. A., Lucas, G. M. & Atta, M. G. Renal disease in patients with HIV infection: epidemiology, pathogenesis and management. Drugs 68, 963\u2013980 (2008).","journal-title":"Drugs"},{"key":"BFnrneph2009140_CR8","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0272-6386(00)70259-9","volume":"35","author":"V Shahinian","year":"2000","unstructured":"Shahinian, V.  et al. Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am. J. Kidney Dis. 35, 884\u2013888 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2009140_CR9","first-page":"125","volume":"2","author":"AH Cohen","year":"1989","unstructured":"Cohen, A. H., Sun, N. C., Shapshak, P. & Imagawa, D. T. Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod. Pathol. 2, 125\u2013128 (1989).","journal-title":"Mod. Pathol."},{"key":"BFnrneph2009140_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/oxfordjournals.ndt.a092263","volume":"8","author":"D Nochy","year":"1993","unstructured":"Nochy, D.  et al. Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol. Dial. Transplant. 8, 11\u201319 (1993).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2009140_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1053\/snep.2001.23771","volume":"21","author":"M Monahan","year":"2001","unstructured":"Monahan, M., Tanji, N. & Klotman, P. E. HIV-associated nephropathy: an urban epidemic. Semin. Nephrol. 21, 394\u2013402 (2001).","journal-title":"Semin. Nephrol."},{"key":"BFnrneph2009140_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1159\/000013537","volume":"19","author":"TS Ahuja","year":"1999","unstructured":"Ahuja, T. S.  et al. Is the prevalence of HIV-associated nephropathy decreasing? Am. J. Nephrol. 19, 655\u2013659 (1999).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2009140_CR13","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJM200106283442604","volume":"344","author":"JA Winston","year":"2001","unstructured":"Winston, J. A.  et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N. Engl. J. Med. 344, 1979\u20131984 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2009140_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2369-4-5","volume":"4","author":"KC Abbott","year":"2003","unstructured":"Abbott, K. C., Trespalacios, F. C., Agodoa, L. Y. & Ahuja, T. S. HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study. BMC Nephrol. 4, 5 (2003).","journal-title":"BMC Nephrol."},{"key":"BFnrneph2009140_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/157488607780598269","volume":"2","author":"M Rho","year":"2007","unstructured":"Rho, M. & Perazella, M. A. Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients. Curr. Drug Saf. 2, 147\u2013154 (2007).","journal-title":"Curr. Drug Saf."},{"key":"BFnrneph2009140_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11908-009-0012-8","volume":"11","author":"CJ Fichtenbaum","year":"2009","unstructured":"Fichtenbaum, C. J. Metabolic abnormalities associated with HIV infection and antiretroviral therapy. Curr. Infect. Dis. Rep. 11, 84\u201392 (2009).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"BFnrneph2009140_CR17","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2215\/CJN.02211205","volume":"6","author":"J Tourret","year":"2006","unstructured":"Tourret, J.  et al. Outcome and prognosis factors in HIV-infected hemodialysis patients. Clin. J. Am. Soc. Nephrol. 6, 1241\u20131247 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2009140_CR18","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1086\/523728","volume":"45","author":"MG Atta","year":"2007","unstructured":"Atta, M. G.  et al. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin. Infect. Dis. 45, 1625\u20131632 (2007).","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 2","key":"BFnrneph2009140_CR19","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1681\/ASN.2005060662","volume":"16","author":"CR Nolan","year":"2005","unstructured":"Nolan, C. R. Strategies for improving long-term survival in patients with ESRD. J. Am. Soc. Nephrol. 16 (Suppl. 2), S120\u2013S127 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009140_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/01.TP.0000075973.73064.A6","volume":"76","author":"PG Stock","year":"2003","unstructured":"Stock, P. G.  et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 76, 370\u2013375 (2003).","journal-title":"Transplantation"},{"key":"BFnrneph2009140_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2006.01238.x","volume":"6","author":"JT Carter","year":"2006","unstructured":"Carter, J. T., Melcher, M. L., Carlson, L. L., Roland, M. E. & Stock, P. G. Thymoglobulin-associated CD4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients. Am. J. Transplant. 6, 753\u2013760 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2009140_CR22","unstructured":"Pelletier, S. J.  et al. Review of transplantation in HIV patients during the HAART era. Clin. Transpl. 63\u201382 (2004)."},{"key":"BFnrneph2009140_CR23","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/01.ASN.0000127987.19470.3A","volume":"15","author":"KC Abbott","year":"2004","unstructured":"Abbott, K. C., Swanson, S. J., Agodoa, L. Y. & Kimmel, P. L. Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J. Am. Soc. Nephrol. 15, 1633\u20131639 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009140_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/01.TP.0000046943.35335.18","volume":"75","author":"ME Roland","year":"2003","unstructured":"Roland, M. E. & Stock, P. G. Review of solid-organ transplantation in HIV-infected patients. Transplantation 75, 425\u2013429 (2003).","journal-title":"Transplantation"},{"key":"BFnrneph2009140_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1600-6143.2007.02061.x","volume":"8","author":"ME Roland","year":"2008","unstructured":"Roland, M. E.  et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am. J. Transplant. 8, 355\u2013365 (2008).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2009140_CR26","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1097\/01.TP.0000145880.38548.0D","volume":"78","author":"HP Tan","year":"2004","unstructured":"Tan, H. P.  et al. Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation 78, 1683\u20131688 (2004).","journal-title":"Transplantation"},{"key":"BFnrneph2009140_CR27","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1111\/j.1523-1755.2005.00245.x","volume":"67","author":"MS Kumar","year":"2005","unstructured":"Kumar, M. S.  et al. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int. 67, 1622\u20131629 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph2009140_CR28","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1089\/aid.2007.0015","volume":"23","author":"JC Trullas","year":"2007","unstructured":"Trullas, J. C.  et al. Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients. AIDS Res. Hum. Retroviruses 23, 1161\u20131165 (2007).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnrneph2009140_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/TP.0b013e318177884e","volume":"86","author":"SA Gruber","year":"2008","unstructured":"Gruber, S. A.  et al. Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates. Transplantation 86, 269\u2013274 (2008).","journal-title":"Transplantation"},{"key":"BFnrneph2009140_CR30","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jhep.2008.02.009","volume":"48","author":"D Samuel","year":"2008","unstructured":"Samuel, D., Weber, R., Stock, P., Duclos-Vallee, J. C. & Terrault, N. Are HIV-infected patients candidates for liver transplantation? J. Hepatol. 48, 697\u2013707 (2008).","journal-title":"J. Hepatol."},{"key":"BFnrneph2009140_CR31","first-page":"559","volume":"35","author":"L Carlson","year":"2008","unstructured":"Carlson, L. Clinical management of the HIV-positive kidney transplant recipient. Nephrol. Nurs. J. 35, 559\u2013567 (2008).","journal-title":"Nephrol. Nurs. J."},{"key":"BFnrneph2009140_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1468-1293.2006.00367.x","volume":"7","author":"S Bhagani","year":"2006","unstructured":"Bhagani, S., Sweny, P., Brook, G. & British HIV Association. Guidelines for kidney transplantation in patients with HIV disease. HIV Med. 7, 133\u2013139 (2006).","journal-title":"HIV Med."},{"key":"BFnrneph2009140_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/tropej\/fml024","volume":"52","author":"F Rouet","year":"2006","unstructured":"Rouet, F.  et al. CD4 percentages and total lymphocyte counts as early surrogate markers for pediatric HIV-1 infection in resource-limited settings. J. Trop. Pediatr. 52, 346\u2013354 (2006).","journal-title":"J. Trop. Pediatr."},{"key":"BFnrneph2009140_CR34","unstructured":"Transplant Study For People with HIV [\n                    online\n                    \n                  ], (2009)."},{"issue":"Suppl. 1","key":"BFnrneph2009140_CR35","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1002\/cyto.b.20398","volume":"74","author":"MR O'Gorman","year":"2008","unstructured":"O'Gorman, M. R. & Zijenah, L. S. CD4 T cell measurements in the management of antiretroviral therapy--A review with an emphasis on pediatric HIV-infected patients. Cytometry B. Clin. Cytom. 74 (Suppl. 1), S19\u2013S26 (2008).","journal-title":"Cytometry B. Clin. Cytom."},{"issue":"Suppl. 3","key":"BFnrneph2009140_CR36","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/S0041-1345(03)00211-2","volume":"35","author":"SN Sehgal","year":"2003","unstructured":"Sehgal, S. N. Sirolimus: its discovery, biological properties, and mechanism of action. Transplant. Proc. 35 (Suppl. 3), S7\u2013S14 (2003).","journal-title":"Transplant. Proc."},{"key":"BFnrneph2009140_CR37","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1128\/AAC.46.11.3447-3455.2002","volume":"46","author":"J Roy","year":"2002","unstructured":"Roy, J., Paquette, J. S., Fortin, J. F. & Tremblay, M. J. The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. Antimicrob. Agents Chemother. 46, 3447\u20133455 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrneph2009140_CR38","doi-asserted-by":"publisher","first-page":"10411","DOI":"10.1073\/pnas.1834278100","volume":"100","author":"A Heredia","year":"2003","unstructured":"Heredia, A.  et al. Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV \u03b2-chemokines: an approach to suppress R5 strains of HIV-1. Proc. Natl Acad. Sci. USA 100, 10411\u201310416 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2009140_CR39","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/314720","volume":"179","author":"O Lesens","year":"1999","unstructured":"Lesens, O., Desch\u00eanes, M., Steben, M., B\u00e9langer, G. & Tsoukas, C. M. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection. J. Infect. Dis. 179, 1254\u20131258 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFnrneph2009140_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/0377-4929.44955","volume":"52","author":"M Jain","year":"2009","unstructured":"Jain, M., Chakravarti, A., Verma, V. & Bhalla, P. Seroprevalence of hepatitis viruses in patients infected with the human immunodeficiency virus. Indian J. Pathol. Microbiol. 52, 17\u201319 (2009).","journal-title":"Indian J. Pathol. Microbiol."},{"key":"BFnrneph2009140_CR41","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-2516.2008.01935.x","volume":"15","author":"MV Ragni","year":"2009","unstructured":"Ragni, M. V., Nalesnik, M. A., Schillo, R. & Dang, Q. Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection. Haemophilia 15, 552\u2013528 (2009).","journal-title":"Haemophilia"},{"key":"BFnrneph2009140_CR42","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1097\/TP.0b013e3181722f3a","volume":"85","author":"FL Luan","year":"2008","unstructured":"Luan, F. L.  et al. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C. Transplantation 85, 1601\u20131606 (2008).","journal-title":"Transplantation"},{"key":"BFnrneph2009140_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/archsurg.2008.508","volume":"144","author":"JE Locke","year":"2009","unstructured":"Locke, J. E., Montgomery, R. A., Warren, D. S., Subramanian, A. & Segev, D. L. Renal transplant in HIV-positive patients: long-term outcomes and risk factors for graft loss. Arch. Surg. 144, 83\u201386 (2009).","journal-title":"Arch. Surg."},{"key":"BFnrneph2009140_CR44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/00126334-199908150-00002","volume":"21","author":"D Margolis","year":"1999","unstructured":"Margolis, D.  et al. Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity. J. Acquir. Immune Defic. Syndr. 21, 362\u2013370 (1999).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFnrneph2009140_CR45","unstructured":"Kaur, R.  et al. A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil. AIDS Res. Ther. 3, 16\u201321 (2006)."},{"key":"BFnrneph2009140_CR46","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.4049\/jimmunol.181.7.4832","volume":"181","author":"KJ Oestreich","year":"2008","unstructured":"Oestreich, K. J., Yoon, H., Ahmed, R. & Boss, J. M. NFATc1 regulates PD-1 expression upon T cell activation. J. Immunol. 181, 4832\u20134839 (2008).","journal-title":"J. Immunol."},{"key":"BFnrneph2009140_CR47","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1073\/pnas.89.9.3686","volume":"89","author":"DA Fruman","year":"1992","unstructured":"Fruman, D. A., Klee, C. B., Bierer, B. E. & Burakoff, S. J. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc. Natl Acad. Sci. USA 89, 3686\u20133690 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2009140_CR48","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.2174\/156802606778194271","volume":"6","author":"C Argyropoulos","year":"2006","unstructured":"Argyropoulos, C. & Mouzaki, A. Immunosuppressive drugs in HIV disease. Curr. Top. Med. Chem. 6, 1769\u20131789 (2006).","journal-title":"Curr. Top. Med. Chem."},{"key":"BFnrneph2009140_CR49","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/01.tp.0000279190.96029.77","volume":"84","author":"PG Stock","year":"2007","unstructured":"Stock, P. G. & Roland, M. E. Evolving clinical strategies for transplantation in the HIV-positive recipient. Transplantation 84, 563\u2013571 (2007).","journal-title":"Transplantation"},{"key":"BFnrneph2009140_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/mc.2940130302","volume":"13","author":"VJ Wacher","year":"1995","unstructured":"Wacher, V. J., Wu, C. Y. & Benet, L. Z. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinog. 13, 129\u2013134 (1995).","journal-title":"Mol. Carcinog."},{"key":"BFnrneph2009140_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijpharm.2002.12.002","volume":"277","author":"LZ Benet","year":"2004","unstructured":"Benet, L. Z., Cummins, C. L. & Wu, C. Y. Unmasking the dynamic interplay between efflux transporters and metabolic enzymes. Int. J. Pharm. 277, 3\u20139 (2004).","journal-title":"Int. J. Pharm."},{"key":"BFnrneph2009140_CR52","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1111\/j.1600-6143.2007.02007.x","volume":"7","author":"LA Frassetto","year":"2007","unstructured":"Frassetto, L. A.  et al. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am. J. Transplant. 7, 2816\u20132820 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2009140_CR53","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1053\/jlts.2003.50171","volume":"9","author":"AB Jain","year":"2003","unstructured":"Jain, A. B.  et al. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl. 9, 954\u2013960 (2003).","journal-title":"Liver Transpl."},{"key":"BFnrneph2009140_CR54","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1053\/jlts.2002.34880","volume":"8","author":"AK Jain","year":"2002","unstructured":"Jain, A. K.  et al. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl. 8, 841\u2013845 (2002).","journal-title":"Liver Transpl."},{"key":"BFnrneph2009140_CR55","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/lt.20165","volume":"10","author":"M Vogel","year":"2004","unstructured":"Vogel, M.  et al. Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir\/ritonavir in liver-transplanted HIV-infected patients. Liver Transpl. 10, 939\u2013944 (2004).","journal-title":"Liver Transpl."},{"key":"BFnrneph2009140_CR56","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.transproceed.2006.02.013","volume":"38","author":"G Guaraldi","year":"2006","unstructured":"Guaraldi, G.  et al. Pharmacokinetic interaction between Amprenavir\/Ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation. Transplant. Proc. 38, 1138\u20131140 (2006).","journal-title":"Transplant. Proc."},{"key":"BFnrneph2009140_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/138920008784746364","volume":"9","author":"T Niwa","year":"2008","unstructured":"Niwa, T., Murayama, N., Emoto, C. & Yamazaki, H. Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5. Curr. Drug Metab. 9, 20\u201333 (2008).","journal-title":"Curr. Drug Metab."},{"key":"BFnrneph2009140_CR58","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/01.qai.0000197075.56397.a5","volume":"41","author":"JB Guiard-Schmid","year":"2006","unstructured":"Guiard-Schmid, J. B., Poirier, J. M., Bonnard, P. & Meynard, J. L. Lack of interaction between atazanavir and proton pump inhibitors in HIV-infected patients treated with ritonavir-boosted atazanavir. J. Acquir. Immune Defic. Syndr. 41, 393\u2013394 (2006).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFnrneph2009140_CR59","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1592\/phco.26.4.511","volume":"26","author":"JJ Kiser","year":"2006","unstructured":"Kiser, J. J., Lichtenstein, K. A., Anderson, P. L. & Fletcher, C. V. Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infection. Pharmacotherapy 26, 511\u2013514 (2006).","journal-title":"Pharmacotherapy"},{"key":"BFnrneph2009140_CR60","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1345\/aph.1H022","volume":"40","author":"PP Fulco","year":"2006","unstructured":"Fulco, P. P., Vora, U. B. & Bearman, G. M. Acid suppressive therapy and the effects on protease inhibitors. Ann. Pharmacother. 40, 1974\u20131983 (2006).","journal-title":"Ann. Pharmacother."},{"key":"BFnrneph2009140_CR61","first-page":"31","volume":"10","author":"A Rashid","year":"1999","unstructured":"Rashid, A.  et al. The impact of hepatitis C infection and antiviral therapy on clinical outcome in renal transplantation recipients. Saudi J. Kidney Dis. Transpl. 10, 31\u201335 (1999).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"BFnrneph2009140_CR62","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1157\/13076175","volume":"23","author":"JM Mir\u00f3","year":"2005","unstructured":"Mir\u00f3, J. M.  et al. GESIDA\/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005) [Spanish]. Enferm. Infecc. Microbiol. Clin. 23, 353\u2013362 (2005).","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"BFnrneph2009140_CR63","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11255-008-9346-7","volume":"40","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy, C. P. & Kalantar-Zadeh, K. Bone and mineral disorders in pre-dialysis CKD. Int. Urol. Nephrol. 40, 427\u2013440 (2008).","journal-title":"Int. Urol. Nephrol."},{"key":"BFnrneph2009140_CR64","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1432-2277.2008.00665.x","volume":"21","author":"C Mitterbauer","year":"2008","unstructured":"Mitterbauer, C. & Oberbauer, R. Bone disease after kidney transplantation. Transpl. Int. 21, 615\u2013624 (2008).","journal-title":"Transpl. Int."},{"key":"BFnrneph2009140_CR65","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/QAI.0b013e31804a7f4d","volume":"45","author":"SE Dolan","year":"2007","unstructured":"Dolan, S. E., Carpenter, S. & Grinspoon, S. Effects of weight, body composition, and testosterone on bone mineral density in HIV-infected women. J. Acquir. Immune. Defic. Syndr. 45, 161\u2013167 (2007).","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"BFnrneph2009140_CR66","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ecl.2007.03.014","volume":"36","author":"RR Kalyani","year":"2007","unstructured":"Kalyani, R. R., Gavini, S. & Dobs, A. S. Male hypogonadism in systemic disease. Endocrinol. Metab. Clin. North Am. 36, 333\u2013348 (2007).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"BFnrneph2009140_CR67","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/QAI.0b013e3181893e8e","volume":"49","author":"DL Jacobson","year":"2008","unstructured":"Jacobson, D. L., Spiegelman, D., Knox, T. K. & Wilson, I. B. Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study. J. Acquir. Immune Defic. Syndr. 49, 298\u2013308 (2008).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFnrneph2009140_CR68","first-page":"23","volume":"99","author":"C Pollet","year":"2002","unstructured":"Pollet, C., Paul, S. M. & Morgan, R. Immunizations in the HIV-infected patient. N. J. Med. 99, 23\u201331 (2002).","journal-title":"N. J. Med."},{"key":"BFnrneph2009140_CR69","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1542-4758.2008.00304.x","volume":"12","author":"ZJ Twardowski","year":"2008","unstructured":"Twardowski, Z. J. Sodium, hypertension, and an explanation of the \u201clag phenomenon\u201d in hemodialysis patients. Hemodial. Int. 12, 412\u2013425 (2008).","journal-title":"Hemodial. Int."},{"key":"BFnrneph2009140_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/0192623308327119","volume":"37","author":"OP Flint","year":"2009","unstructured":"Flint, O. P.  et al. The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications. Toxicol. Pathol. 37, 65\u201377 (2009).","journal-title":"Toxicol. Pathol."},{"key":"BFnrneph2009140_CR71","doi-asserted-by":"publisher","first-page":"F2","DOI":"10.1152\/ajprenal.00072.2007","volume":"293","author":"NA Bobadilla","year":"2007","unstructured":"Bobadilla, N. A. & Gamba, G. New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. Am. J. Physiol. Renal. Physiol. 293, F2\u2013F9 (2007).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"BFnrneph2009140_CR72","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3810\/pgm.2008.07.1792","volume":"120","author":"LR Reynolds","year":"2008","unstructured":"Reynolds, L. R. & Tannock, L. R. Management of new-onset diabetes mellitus after transplantation. Postgrad. Med. 120, 60\u201366 (2008).","journal-title":"Postgrad. Med."},{"key":"BFnrneph2009140_CR73","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1023\/A:1026132412074","volume":"17","author":"A Corsini","year":"2003","unstructured":"Corsini, A. The safety of HMG-CoA reductase inhibitors in special populations at high cardiovascular risk. Cardiovasc. Drugs Ther. 17, 265\u2013285 (2003).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"BFnrneph2009140_CR74","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","volume":"351","author":"JJ Goedert","year":"1998","unstructured":"Goedert, J. J.  et al. Spectrum of AIDS-associated malignant disorders. Lancet 351, 1833\u20131839 (1998).","journal-title":"Lancet"},{"key":"BFnrneph2009140_CR75","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/978-1-59745-416-2_20","volume":"471","author":"D Serraino","year":"2009","unstructured":"Serraino, D., Piselli, P. & Immunosuppression and Cancer Study Group. Cancer cohort consortium approach: cancer epidemiology in immunosuppressed groups. Methods Mol. Biol. 471, 409\u2013419 (2009).","journal-title":"Methods Mol. Biol."},{"key":"BFnrneph2009140_CR76","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ijc.23487","volume":"123","author":"EA Engels","year":"2008","unstructured":"Engels, E. A.  et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int. J. Cancer 123, 187\u2013194 (2008).","journal-title":"Int. J. Cancer"},{"key":"BFnrneph2009140_CR77","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3748\/wjg.14.1657","volume":"14","author":"DC MacDonald","year":"2008","unstructured":"MacDonald, D. C., Nelson, M., Bower, M. & Powles, T. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. World J. Gastroenterol. 14, 1657\u20131663 (2008).","journal-title":"World J. Gastroenterol."},{"key":"BFnrneph2009140_CR78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1529-8019.2005.05009.x","volume":"18","author":"PV Chin-Hong","year":"2005","unstructured":"Chin-Hong, P. V. & Palefsky, J. M. Human papillomavirus anogenital disease in HIV-infected individuals. Dermatol. Ther. 18, 67\u201376 (2005).","journal-title":"Dermatol. Ther."},{"key":"BFnrneph2009140_CR79","first-page":"113","volume":"26","author":"A Mazuecos","year":"2006","unstructured":"Mazuecos, A.  et al. Renal transplantation in HIV-infected patients in Spain [Spanish]. Nefrologia 26, 113\u2013120 (2006).","journal-title":"Nefrologia"},{"key":"BFnrneph2009140_CR80","first-page":"664","volume":"16","author":"ME Roland","year":"2006","unstructured":"Roland, M. E., Carlson, L. L., Frassetto, L. A. & Stock, P. G. Solid organ transplantation: referral, management, and outcomes in HIV-infected patients. AIDS Read. 16, 664\u2013668, 675\u2013678 (2006).","journal-title":"AIDS Read."},{"key":"BFnrneph2009140_CR81","unstructured":"USPHS\/IDSA Prevention of Opportunistic Infections Working Group. 1999 USPHS\/IDSA guidelines for the prevention of opportunistic infections in person infected with Human Immunodeficiency Virus. MMWR 48, 10 (1999)."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.140","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:31:17Z","timestamp":1684470677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2009.140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["BFnrneph2009140"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2009.140","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}